These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 4211415

  • 1. [Effect of saturation of Mycobacterium tuberculosis--a theoretical basis of the method of mazimum concentration of tuberculostatic preparations].
    Bondarev IM.
    Probl Tuberk; 1974; 52(6):58-64. PubMed ID: 4211415
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH.
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract] [Full Text] [Related]

  • 5. [Complex research studies in the testing of the effectiveness of phenaside].
    Sel'tsovskiĭ PP, Irtuganova OA, Slogotskaia LV, Smirnova NS, Moroz AM, Borzenko AS, Spasov AA, Smirnova LA, Dzhura PI, Karpov AV, Ivanovskiĭ VB, Pauker MN, Plemiannikova GI.
    Probl Tuberk; 2001 Jun; (8):29-31. PubMed ID: 11767386
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The clinical importance of the primary drug resistance of Mycobacterium tuberculosis in destructive forms of pulmonary tuberculosis].
    Khomenko AG, Chesak OI, Biazov TA, Chaikina TN.
    Probl Tuberk; 1972 Jun; 50(10):28-32. PubMed ID: 4633557
    [No Abstract] [Full Text] [Related]

  • 9. Would you know one if you met one?
    Grange JM.
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1162-3. PubMed ID: 11769777
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Research on the ultrastructure of certain strains of Mycobacteria isolated from tuberculosis patients, with different sensitivity to isoniazid and streptomycin].
    Radanov R, Spassova N, Kalfin E.
    Ann Sclavo; 1972 Dec; 14(1):103-12. PubMed ID: 4205219
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Studies of early bactericidal activity: new insights into isoniazid pharmacokinetics.
    Gillespie SH.
    Clin Infect Dis; 2004 Nov 15; 39(10):1431-2. PubMed ID: 15546076
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The advantages of the antituberculosis regimens which include Sinerdol-EH, a new tuberculostatic of rifampicin-type.
    Păunescu E.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983 Nov 15; 32(1):33-42. PubMed ID: 6312533
    [No Abstract] [Full Text] [Related]

  • 16. [Resistance of Mycobacterium tuberculosis in Ferrol, Spain. Associated factors].
    García Rodríguez JF, Mariño Callejo A, Lorenzo García MV, Rodríguez Mayo M, Domínguez Gómez D, Sesma Sánchez P.
    Med Clin (Barc); 1999 Nov 06; 113(15):572-4. PubMed ID: 10605682
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Determination of Mycobacterium tuberculosis' sensitivity to pyrazinamide on a BACTEC-960 bacteriological analyzer].
    Irtuganova OA, Smirnova NS, Slogotskaia LV.
    Probl Tuberk Bolezn Legk; 2003 Nov 06; (7):40-2. PubMed ID: 12939878
    [No Abstract] [Full Text] [Related]

  • 20. [Drug dependance of Mycobacterium tuberculosis].
    Mel'nikov EL.
    Probl Tuberk; 1969 Nov 06; 47(5):60-4. PubMed ID: 4983819
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.